About the Journal

Overview

The Annals of Medical and Surgical Oncology (AMSO) is an international, peer-reviewed, open-access journal published by UMed Press.
AMSO is dedicated to advancing the field of oncology by publishing rigorous, evidence-based research that spans both medical and surgical oncology disciplines. The journal provides a global platform for clinicians, researchers, and academic scholars to share novel findings, multidisciplinary perspectives, and emerging innovations in cancer diagnosis, treatment, and prevention.

AMSO emphasizes scientific integrity, clinical relevance, and the translation of research into improved patient outcomes and healthcare practices.

Aims and Scope

The Annals of Medical and Surgical Oncology aims to promote collaboration across oncological disciplines and to serve as a bridge between research, clinical practice, and innovation.
The journal welcomes original research articles, systematic reviews, clinical trials, meta-analyses, and case studies in, but not limited to, the following areas:

  • Medical oncology and chemotherapy

  • Surgical oncology and oncologic surgery

  • Radiation oncology

  • Immunotherapy and targeted therapies

  • Cancer genetics and molecular biology

  • Oncopathology and biomarker research

  • Palliative and supportive care

  • Cancer prevention, screening, and epidemiology

  • Translational and experimental oncology

Through interdisciplinary publication, AMSO strives to contribute to precision medicine and integrated cancer care.

Mission

To advance excellence in oncology research and clinical practice by disseminating credible, high-quality, and globally accessible scientific knowledge.

AMSO’s mission is to connect researchers and clinicians worldwide, fostering innovation in cancer research, treatment strategies, and multidisciplinary collaboration for better patient care and survival outcomes.

Editorial and Peer Review Policy

  • Manuscripts are subjected to a double-blind peer review process conducted by experts in relevant subfields.

  • Each submission is checked for originality and plagiarism using iThenticate software.

  • Editorial decisions are based on scientific quality, methodological soundness, and ethical compliance.

  • The journal follows COPE, ICMJE, and OASPA publishing standards to ensure transparency and integrity.

Open Access and Licensing

AMSO operates under a fully open-access model, ensuring that published content is freely available to readers, researchers, and practitioners worldwide.
All articles are distributed under the Creative Commons Attribution (CC BY 4.0) license, allowing unrestricted use, sharing, and adaptation with appropriate citation.

Indexing and Digital Preservation

To ensure long-term accessibility, discoverability, and citation tracking, AMSO:

  • Assigns Crossref DOIs to all published articles.

  • Implements digital archiving through LOCKSS, CLOCKSS, and the PKP Preservation Network (PKP PN).

  • Complies with technical and ethical standards required for indexing in Scopus, Web of Science, and DOAJ.

Target Audience

  • Oncologists and cancer researchers

  • Surgeons and clinical practitioners

  • Biomedical scientists and pharmacologists

  • Healthcare policymakers and educators

  • Multidisciplinary teams in oncology and palliative care